Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for ATORVASTATIN

Ingredient

ATORVASTATIN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TARO-ATORVASTATIN	40MG	TABLET	Resolved	2023-08-16	2025-01-07	202110
TARO-ATORVASTATIN	20MG	TABLET	Resolved	2024-11-11	2025-01-07	242487
TARO-ATORVASTATIN	20MG	TABLET	Resolved	2023-08-16	2025-01-07	202104
TARO-ATORVASTATIN	20MG	TABLET	Resolved	2023-08-16	2024-10-17	202101
TARO-ATORVASTATIN	10MG	TABLET	Resolved	2024-11-11	2025-01-07	242482
TARO-ATORVASTATIN	40MG	TABLET	Resolved	2023-08-16	2024-10-17	202107
TARO-ATORVASTATIN	10MG	TABLET	Resolved	2023-08-16	2024-10-17	202095
TEVA-ATORVASTATIN	20MG	TABLET	Resolved	2022-12-08	2023-01-12	177511
TEVA-ATORVASTATIN	20MG	TABLET	Resolved	2020-01-30	2020-02-13	104884
TEVA-ATORVASTATIN	20MG	TABLET	Resolved	2021-06-17	2021-07-09	141110

Previous
1
…
21
22
23
24
25
…
29
Next

Showing 221 to 230 of 282

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
TEVA-ATORVASTATIN	80MG	TABLET	Reversed	2025-05-28	2025-06-04	258655

Previous
1
…
4
5
6

Showing 51 to 51 of 51